Total Payments
$53,900
2024 Payments
$1,122
Companies
34
Transactions
545
Medicare Patients
5,225
Medicare Billing
$511,287
Payment Breakdown by Category
Other$39,600 (73.5%)
Food & Beverage$10,420 (19.3%)
Travel$3,715 (6.9%)
Education$165.61 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $39,600 | 19 | 73.5% |
| Food and Beverage | $10,420 | 494 | 19.3% |
| Travel and Lodging | $3,715 | 21 | 6.9% |
| Education | $165.61 | 11 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $49,591 | 296 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $747.71 | 53 | $0 (2024) |
| Janssen Biotech, Inc. | $436.83 | 25 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $411.61 | 22 | $0 (2023) |
| INTERCEPT PHARMACEUTICALS, INC. | $373.68 | 19 | $0 (2023) |
| Merck Sharp & Dohme LLC | $301.40 | 18 | $0 (2024) |
| Daiichi Sankyo Inc. | $240.73 | 8 | $0 (2024) |
| Allergan, Inc. | $234.77 | 17 | $0 (2020) |
| PFIZER INC. | $218.11 | 13 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $161.07 | 9 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,122 | 58 | ABBVIE INC. ($661.70) |
| 2023 | $3,750 | 78 | ABBVIE INC. ($2,946) |
| 2022 | $11,245 | 99 | ABBVIE INC. ($10,540) |
| 2021 | $5,081 | 59 | AbbVie Inc. ($4,565) |
| 2020 | $576.93 | 32 | AbbVie Inc. ($175.53) |
| 2019 | $10,446 | 72 | AbbVie, Inc. ($10,055) |
| 2018 | $7,261 | 57 | AbbVie, Inc. ($6,919) |
| 2017 | $14,419 | 90 | AbbVie, Inc. ($13,728) |
All Payment Transactions
545 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.40 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: LIVER DISEASE | ||||||
| 11/12/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), Linzess | Food and Beverage | Cash or cash equivalent | $15.78 | General |
| Category: GI | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: LIVER DISEASE | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.87 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $119.03 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: VIROLOGY | ||||||
| 09/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $22.19 | General |
| 08/27/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $27.95 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.39 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $19.36 | General |
| 07/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,259 | 1,466 | $643,850 | $123,588 |
| 2022 | 19 | 1,377 | 1,569 | $690,418 | $128,178 |
| 2021 | 20 | 1,332 | 1,572 | $714,387 | $134,934 |
| 2020 | 18 | 1,257 | 1,455 | $661,970 | $124,587 |
Total Patients
5,225
Total Services
6,062
Medicare Billing
$511,287
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 111 | 111 | $127,940 | $20,753 | 16.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 174 | 180 | $91,524 | $12,359 | 13.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 139 | 184 | $24,822 | $11,261 | 45.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 110 | 116 | $26,100 | $11,132 | 42.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 56 | 56 | $43,425 | $9,454 | 21.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 62 | 64 | $61,682 | $7,736 | 12.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 89 | 207 | $14,490 | $7,580 | 52.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 45 | 45 | $33,795 | $7,438 | 22.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 61 | 61 | $49,870 | $7,203 | 14.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 83 | 85 | $45,605 | $6,130 | 13.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 51 | $10,156 | $4,627 | 45.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 54 | 54 | $9,471 | $3,852 | 40.7% |
| 43450 | Dilation of esophagus | Facility | 2023 | 106 | 114 | $39,917 | $3,201 | 8.0% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 24 | 34 | $21,420 | $3,094 | 14.4% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2023 | 17 | 20 | $22,322 | $2,919 | 13.1% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 12 | 14 | $11,900 | $2,054 | 17.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 25 | 25 | $2,875 | $1,028 | 35.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 17 | 17 | $2,996 | $985.12 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 11 | 12 | $1,620 | $563.40 | 34.8% |
| 17250 | Application of chemical to stop tissue regrowth in wound | Facility | 2023 | 14 | 16 | $1,920 | $218.61 | 11.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 98 | 100 | $115,250 | $17,905 | 15.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 134 | 140 | $31,500 | $13,866 | 44.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 180 | 187 | $95,293 | $13,677 | 14.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 142 | 175 | $23,601 | $10,601 | 44.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 59 | 59 | $44,790 | $9,942 | 22.2% |
About Dr. Robert Mcclure, MD
Dr. Robert Mcclure, MD is a Gastroenterology healthcare provider based in Columbia, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386600906.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Mcclure, MD has received a total of $53,900 in payments from pharmaceutical and medical device companies, with $1,122 received in 2024. These payments were reported across 545 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($39,600).
As a Medicare-enrolled provider, Mcclure has provided services to 5,225 Medicare beneficiaries, totaling 6,062 services with total Medicare billing of $511,287. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Columbia, TN
- Active Since 04/22/2006
- Last Updated 06/23/2010
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1386600906
Products in Payments
- Mavyret (Drug) $21,287
- MAVYRET (Drug) $16,945
- Viekira (Drug) $8,874
- SKYRIZI (Biological) $744.86
- RINVOQ (Biological) $518.26
- Humira (Biological) $421.53
- HUMIRA (Biological) $392.98
- XIFAXAN (Drug) $382.30
- OCALIVA (Drug) $373.68
- TRULANCE (Drug) $267.33
- STELARA (Biological) $256.88
- INJECTAFER (Drug) $240.73
- LINZESS (Drug) $233.30
- ENTYVIO (Biological) $227.97
- DIFICID (Drug) $227.73
- XELJANZ (Drug) $218.11
- CREON (Drug) $181.40
- REMICADE (Biological) $179.95
- Trulance (Drug) $134.16
- GATTEX (Drug) $111.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Columbia
Rudrajit Rai, Md, MD
Gastroenterology — Payments: $345,636
Gastroenterology $345,636
Dr. Joseph Meserve, M.d, M.D
Gastroenterology — Payments: $86,610
Gastroenterology $86,610
Kenneth Vega, Md, MD
Gastroenterology — Payments: $60,525
Gastroenterology $60,525
Bradley Anderson, Md, MD
Gastroenterology — Payments: $57,839
Gastroenterology $57,839
Dr. Michael Williams, Md, MD
Gastroenterology — Payments: $48,728
Gastroenterology $48,728
Mr. Balbir Minhas, Md, MD
Gastroenterology — Payments: $33,515
Gastroenterology $33,515